|Day's Range||74.68 - 76.00|
|52 Week Range||65.47 - 99.14|
|PE Ratio (TTM)||-3.14|
|Earnings Date||Aug 8, 2017 - Aug 14, 2017|
|Dividend & Yield||0.64 (0.85%)|
|1y Target Est||75.87|
Health care stocks got a lift Thursday after Senate Republicans rolled out their proposed bill to repeal Obamacare.
DUBLIN , June 21, 2017 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality Affordable Healthcare Products ® ", today announced that the Company's Board ...
TASE: PRGO) today announced it has launched its generic equivalents to Hill Laboratories Inc.'s Derma-Smoothe/FS® Scalp Oil (fluocinolone acetonide scalp oil, 0.01%) and Derma-Smoothe/FS® Body Oil (fluocinolone acetonide topical oil, 0.01%). Derma-Smoothe/FS® Scalp Oil (fluocinolone acetonide scalp oil, 0.01%) and Derma-Smoothe/FS® Body Oil (fluocinolone acetonide topical oil, 0.01%) are indicated for the topical treatment of atopic dermatitis in adult patients and the topical treatment of moderate to severe atopic dermatitis in pediatric patients 3 months and older for up to four weeks. Perrigo CEO John T. Hendrickson stated, "This launch is another example of Perrigo's ability to develop and bring to market important extended topical treatments.